{
    "title": "111_hr2134",
    "content": "The Act may be cited as the \"Western Hemisphere Drug Policy Commission Act of 2009\". Congress finds that in 2008, there were millions of users of marijuana, cocaine, methamphetamine, and heroin in the United States. The majority of cocaine and heroin in the US originates from Andean countries and Colombia and Mexico, respectively. The majority of the United States heroin supply comes from Colombia and Mexico, leading to violence, instability, and corruption in those countries. Drug trafficking in Central America, Mexico, Venezuela, and other Caribbean countries poses a threat to law enforcement, political institutions, and citizen security. Drug trafficking in Mexico is fueling organized crime and violence, with 5,661 deaths in 2008 alone. Criminal networks also traffic Mexican women and girls into the United States. According to the Department of State's June 2009 Trafficking in Persons report, organized criminal networks in Mexico traffic women and girls into the United States for sexual exploitation. Extremist groups in the Western Hemisphere, such as FARC and Hezbollah, use drug trafficking to fund terrorist activities. United States counternarcotics assistance has been provided to Latin America from 1980-2008. From 1980-2008, the United States provided about $11.3 billion in counternarcotics assistance to Latin America and the Caribbean to combat drug trafficking used by groups like FARC and Hezbollah to finance terrorist activities. The Western Hemisphere Drug Policy Commission is established to review and evaluate US policies on illicit drug supply reduction and interdiction, focusing on international drug policies in the Western Hemisphere. The Commission will identify options to improve existing counternarcotics policies. The Commission will review US policies on illicit drug supply reduction, interdiction, and demand reduction, focusing on international drug control policies in the Western Hemisphere. Topics include drug interdiction efforts, crop eradication programs, and the impact of the Andean Counterdrug Initiative (ACI). The Commission will assess drug interdiction efforts, crop eradication programs, economic development alternatives, the impact of initiatives like ACI and Merida, deployment of technology against drug cartels, and efforts to curb trafficking of chemical precursors for illicit drugs in the Western Hemisphere. The Commission will assess the deployment of technology against drug cartels, efforts to curb trafficking of chemical precursors for illicit drugs, the United States drug certification process, the population's demand for illicit drugs, and drug prevention and treatment programs. An assessment of United States drug prevention and treatment programs, including anti-drug coalitions, drug courts, and programs aimed at preventing recidivism, as well as the extent of illicit drug consumption driven by addiction and effective treatment experiences. The curr_chunk discusses recommendations for improving US policies on illicit drugs, assessing support for reducing supply and demand in other countries, and evaluating indicators of success. The curr_chunk discusses assessing indicators of success in US illicit drug control policy and coordinating with entities in other countries to reduce supply and demand for drugs. The Commission will consult with government, academic, and nongovernmental leaders in the Western Hemisphere, as well as the Inter-American Drug Abuse Control Commission (CICAD) to enhance effectiveness. A report must be submitted within 12 months of the first meeting. The Commission will consult with various stakeholders, including the Inter-American Drug Abuse Control Commission (CICAD), to enhance effectiveness. A report must be submitted to relevant committees within 12 months of the first meeting. The Commission will submit a report to key committees containing recommendations, findings, and conclusions. The Commission will submit a detailed report to key committees, including recommendations, findings, and conclusions, which will be made available to the public. SEC. 6. MEMBERSHIP. The Commission shall consist of ten members appointed by various leaders, excluding current government officials. Each member serves for the duration of the Commission. The Commission consists of ten members appointed by leaders, excluding current government officials. Members serve for the life of the Commission, vacancies are filled promptly, and appointments must be made within 30 days of the Act's enactment. Within 60 days, the Commission must hold an initial meeting to establish a schedule and select a chairperson. The Commission shall hold an initial meeting within 60 days of enactment to select a Chairperson and develop a schedule. Six members constitute a quorum, and members receive travel expenses as per regulations. The Commission requires six members for a quorum. Members are entitled to travel expenses as per regulations. SEC. 7. POWERS. The Commission has the power to hold meetings, conduct hearings, and access necessary resources from various government agencies to fulfill its duties. The Commission can access resources from government agencies like the Library of Congress, Office of National Drug Control Policy, Department of State, Department of Health and Human Services, Department of Justice, Drug Enforcement Administration, Department of Defense, and others. The General Services Administration provides office space for Commission activities and meetings upon request. The General Services Administration provides office space for Commission activities and meetings upon request. The Commission has the authority to use the United States mails and to contract for services. The Commission has the authority to use the United States mails and enter into contracts for necessary activities, with agreements not extending beyond its termination date. SEC. 8. STAFF. The Commission shall have an Executive Director who can appoint necessary staff paid at a rate not exceeding level IV of the Executive Schedule. The Commission may appoint additional personnel without following standard appointment procedures. The Commission may appoint additional personnel as necessary for its duties, with compensation not bound by standard regulations. The Executive Director can also procure temporary services with Commission approval. The Executive Director may procure temporary services with Commission approval and request personnel details from Federal agencies to assist in carrying out the Commission's duties without affecting their civil service status. Authorization of $2,000,000 for the Western Hemisphere Drug Policy Commission without fiscal year limitation. The Commission will terminate 60 days after submitting its report to Congress."
}